Molecular Mechanisms of Muscle Fatigue, 2021, Constantin-Teodosiu and Constantin

Discussion in 'Other health news and research' started by Andy, Nov 16, 2021.

  1. Andy

    Andy Committee Member

    Messages:
    23,032
    Location:
    Hampshire, UK
    Abstract

    Muscle fatigue (MF) declines the capacity of muscles to complete a task over time at a constant load. MF is usually short-lasting, reversible, and is experienced as a feeling of tiredness or lack of energy. The leading causes of short-lasting fatigue are related to overtraining, undertraining/deconditioning, or physical injury. Conversely, MF can be persistent and more serious when associated with pathological states or following chronic exposure to certain medication or toxic composites. In conjunction with chronic fatigue, the muscle feels floppy, and the force generated by muscles is always low, causing the individual to feel frail constantly.

    The leading cause underpinning the development of chronic fatigue is related to muscle wasting mediated by aging, immobilization, insulin resistance (through high-fat dietary intake or pharmacologically mediated Peroxisome Proliferator-Activated Receptor (PPAR) agonism), diseases associated with systemic inflammation (arthritis, sepsis, infections, trauma, cardiovascular and respiratory disorders (heart failure, chronic obstructive pulmonary disease (COPD))), chronic kidney failure, muscle dystrophies, muscle myopathies, multiple sclerosis, and, more recently, coronavirus disease 2019 (COVID-19).

    The primary outcome of displaying chronic muscle fatigue is a poor quality of life. This type of fatigue represents a significant daily challenge for those affected and for the national health authorities through the financial burden attached to patient support. Although the origin of chronic fatigue is multifactorial, the MF in illness conditions is intrinsically linked to the occurrence of muscle loss. The sequence of events leading to chronic fatigue can be schematically denoted as: trigger (genetic or pathological) -> molecular outcome within the muscle cell -> muscle wasting -> loss of muscle function -> occurrence of chronic muscle fatigue.

    The present review will only highlight and discuss current knowledge on the molecular mechanisms that contribute to the upregulation of muscle wasting, thereby helping us understand how we could prevent or treat this debilitating condition.

    Open access, https://www.mdpi.com/1422-0067/22/21/11587/htm
     
    Snow Leopard, Simbindi, shak8 and 2 others like this.
  2. Snow Leopard

    Snow Leopard Senior Member (Voting Rights)

    Messages:
    3,860
    Location:
    Australia
    I am not a fan of this narrative review - the authors display poor understanding of the neurology and exercise physiology of fatigue - too many oversimplifications and errors for me to take it seriously. And the biochemistry reminds me a lot of a certain discussion thread back on Phoenix Rising.
     
    FMMM1, Mithriel, shak8 and 2 others like this.

Share This Page